GL1X · GenesisL1 explorer

MolNFT v1 · #91801 · protein

Crystal structure of lincosamide antibiotic adenylyltransferase lnua, apo

4FO1 · Lincosamide resistance protein: “Crystal structure of lincosamide antibiotic adenylyltransferase lnua, apo”. X-ray diffraction, 2 pockets (best druggability 0.48). MolNFT v1 #91801 on GenesisL1: 3D structure, binding sites and…

PDB
4FO1
Type
protein
Length
316 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lincosamide resistance protein
UniProt
P06107
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BLincosamide resistance proteinprotein15836% helix, 32% strandP06107

Ligands and binding sites

  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12190.480.7528EPE
21990.470.7526EPE

Interfaces

1 interface between chains.

  • A–B · 109 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 modified (engineered).

Compared structures

  • 4FO1 · Crystal structure of lincosamide antibiotic adenylyltransferase LnuA, apo · the same entry in another collection · chain A against A, TM-score 1.00
  • P06107 · AlphaFold monomer V2.0 prediction for lincosamide resistance protein (P06107) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.